Daily Bulletin

Men's Weekly

.

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases

  • Secarna's LNAplus™ ASOs suppress expression of NLRP3, a central component of the inflammasome pathway, which is overactive in many inflammatory diseases
  • Cryopyrin-associated periodic syndrome (CAPS) is a group of rare inherited autoinflammatory diseases driven by overactive NLRP3, resulting in systemic inflammation
  • With NLRP3-specific ASOs, inflammatory downstream effects were interrupted in immune cells and strong symptom relief and significant prolongation of survival was achieved in a CAPS disease model.

Business News

China Gold Coin Group Launched 2026 Chinese Dragon Silver Bullion Coin at World Money Fair in Berlin

China Gold Coin Group Co., Ltd. unveiled its 2026 Chinese Dragon Silver Bullion Coin at the World Money Fair held in Berlin, Germany, from January 29 to 31. Led by Mr Jinpu Jiao, Chairman of the Boa...

Daily Bulletin - avatar Daily Bulletin

How to Choose the Right Industrial Air Compressor for Your Business

Running a business is all about making the right decisions. When it comes to choosing an industrial air compressor, that decision becomes even more critical. Air compressors are long-term investment...

Daily Bulletin - avatar Daily Bulletin

Manhari Founder, Maddy Gupta, urges businesses to capitalise on the rising value of metals

Old and unwanted equipment and business assets are often worth far more than they appear particularly those containing valuable metals. Precious metals, led by gold and silver reaching record highs...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business